Breast Cancer Drug Abandoned By 36% Of Patients Due To Side Effects

[News]

36% of post-menopausal breast cancer patients who take aromatase inhibitors do not complete their treatment, because the drug's side effects are so unpleasant, researchers from the Northwestern University Feinberg School of Medicine reported at the San Antonio Breast Cancer Symposium...

More... (http://www.medicalnewstoday.com/articles/239020.php)